Fill out the form below to download your copy.
This inaugural edition of DeciBio’s IVD report provides an overview of the In Vitro Diagnostics (IVD) market from 2012 to 2018. IVD companies offer diagnostic instruments, reagents and services to clinical laboratories. These tests are marketed and sold specifically for the purpose of patient diagnosis and treatment decision making, and as such must be approved for this purpose by governing regulatory bodies (e.g. FDA or CE Mark approval). This market report excludes laboratory developed tests (LDTs) since they do not use IVD kits / assays.